APPENDIX A: Drugs used during the treatment of cardiac arrest.
The effective management of cardiac arrest involves timely administration of drugs alongside high-quality CPR and defibrillation. This section details the key drugs used in resuscitation, their indica…
The effective management of cardiac arrest involves timely administration of drugs alongside high-quality CPR and defibrillation. This section details the key drugs used in resuscitation, their indications, doses, and mechanisms of action.
Adrenaline (Epinephrine)
Role in Cardiac Arrest
- A critical vasopressor that increases coronary and cerebral perfusion pressure during CPR.
- Enhances myocardial contractility and promotes the return of spontaneous circulation (ROSC).
Indications & Administration
- Given for shockable (VF/pVT) and non-shockable (asystole/PEA) cardiac arrests.
- Dose: 1 mg IV/IO every 3-5 minutes during cardiac arrest.
- First dose timing:
- After the third shock for shockable rhythms (VF/pVT).
- Immediately after vascular access for non-shockable rhythms (asystole/PEA).
- Adverse Effects: Can cause hypertension, tachycardia, and arrhythmias post-ROSC.
Amiodarone
Role in Cardiac Arrest
- A class III antiarrhythmic that stabilises cardiac membranes by blocking potassium channels.
- Used to terminate shock-resistant ventricular fibrillation (VF) and pulseless ventricular tachycardia (pVT).
Indications & Administration
- Dose: 300 mg IV/IO after the third shock for persistent VF/pVT.
- A repeat dose of 150 mg may be given if VF/pVT persists.
- Always followed by a flush to ensure drug delivery.
- Contraindications: Avoid in cases of severe bradycardia, heart block, or hypotension.
Lidocaine (Alternative to Amiodarone)
Role in Cardiac Arrest
- A sodium channel blocker used as an alternative to amiodarone for VF/pVT refractory to defibrillation.
- It reduces myocardial excitability and suppresses ectopic ventricular activity.
Indications & Administration
- Dose: 1 mg/kg IV/IO, followed by further doses up to 3 mg/kg if needed.
- Do NOT use lidocaine if amiodarone has already been administered.
- Adverse effects: Can cause neurological toxicity, including seizures and altered consciousness in overdose.
Magnesium Sulphate
Role in Cardiac Arrest
- Primarily used for Torsades de Pointes (polymorphic VT associated with QT prolongation).
- Helps in cases of hypomagnesaemia, which can lead to arrhythmias.
Indications & Administration
- Dose: 2 g IV/IO over 1-2 minutes for Torsades de Pointes or suspected hypomagnesaemia.
- Adverse effects: High doses may cause hypotension, respiratory depression, and cardiac arrest.
Calcium Chloride
Role in Cardiac Arrest
- Used in specific cases, including hyperkalaemia, hypocalcaemia, and calcium channel blocker overdose.
- Helps restore cardiac excitability and contractility.
Indications & Administration
- Dose: 10 mL of 10% calcium chloride IV/IO for severe hyperkalaemia or overdose.
- Not routinely given in cardiac arrest unless indicated.
- Adverse effects: Can cause tissue necrosis if extravasation occurs.
Sodium Bicarbonate
Role in Cardiac Arrest
- Buffering agent used to correct severe metabolic acidosis.
- Only considered in prolonged resuscitation efforts or specific cases.
Indications & Administration
- Dose: 50 mmol IV/IO slow push, repeated as necessary.
- Used for hyperkalaemia, tricyclic antidepressant overdose, or prolonged cardiac arrest with severe acidosis.
- Routine use is NOT recommended due to risks of worsening intracellular acidosis.
Naloxone (Opioid Reversal)
Role in Cardiac Arrest
- Used to reverse opioid-induced respiratory depression in suspected opioid overdose.
- Not a primary drug for cardiac arrest unless opioid toxicity is suspected.
Indications & Administration
- Dose: 0.4–2 mg IV/IO every 2-3 minutes as needed (max 10 mg).
- Considered in cardiac arrest due to suspected opioid toxicity.
Summary Table: Drug Use in Cardiac Arrest
| Drug | Indication | Dose & Route | Key Considerations |
|---|---|---|---|
| Adrenaline | VF/pVT, Asystole, PEA | 1 mg IV/IO every 3-5 min | Give immediately in non-shockable rhythms. Delays worsen survival. |
| Amiodarone | Shock-resistant VF/pVT | 300 mg IV/IO (after 3rd shock), then 150 mg | Avoid in severe bradycardia/hypotension. |
| Lidocaine | Alternative to Amiodarone for VF/pVT | 1 mg/kg IV/IO, up to 3 mg/kg | Do not use if amiodarone was already given. |
| Magnesium Sulphate | Torsades de Pointes, Hypomagnesaemia | 2 g IV/IO over 1-2 min | Can cause hypotension, respiratory depression. |
| Calcium Chloride | Hyperkalaemia, Hypocalcaemia, CCB overdose | 10 mL of 10% CaCl IV/IO | Not routine. Avoid extravasation. |
| Sodium Bicarbonate | Severe acidosis, TCA overdose, hyperkalaemia | 50 mmol IV slow push | Not routinely used. Can worsen acidosis. |
| Naloxone | Opioid toxicity with respiratory depression | 0.4-2 mg IV/IO | Used in suspected opioid overdose. |
Key Takeaways
✔ Drugs are secondary to high-quality CPR and defibrillation in cardiac arrest.
✔ Adrenaline is the most critical drug, but timing matters—give early in non-shockable rhythms and after the third shock in shockable rhythms.
✔ Antiarrhythmic drugs (amiodarone or lidocaine) should be used selectively.
✔ Reversible causes (e.g., hyperkalaemia, opioid overdose, metabolic acidosis) guide additional drug therapy.
✔ Routine administration of sodium bicarbonate and calcium is NOT recommended unless specifically indicated.